Rare diseases
Investigational molecules
Locations
264 Mesogion Avenue, 15562 Cholargos, Greece
Metropolitan General Hospital in Cholargos, Greece specialises in clinical trials of conditions such as Atrial fibrillation, Hormone-refractory prostate cancer, Prostate cancer metastatic, Prostate cancer, and other specialisations. This site conducts important research.
The Cardiology department at Metropolitan General Hospital is evaluating new strategies to lower the risk of ischemic stroke in patients with atrial fibrillation who cannot take oral anticoagulants.
This work aims to improve outcomes for high‑risk heart rhythm patients and could expand treatment options beyond traditional blood thinners.
Researchers are testing a combination of capivasertib and docetaxel in men with metastatic castration‑resistant prostate cancer to see if it extends overall survival and delays disease progression.
The trial reflects Metropolitan General Hospital’s commitment to advancing cancer therapy and offering hope to patients with advanced prostate disease.
Clinical trials currently enrolling participants at this site.
GreeceGreeceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
